Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 3
1968 5
1969 8
1970 10
1971 17
1972 11
1973 9
1974 32
1975 52
1976 76
1977 120
1978 50
1979 79
1980 112
1981 74
1982 72
1983 78
1984 91
1985 76
1986 81
1987 74
1988 99
1989 110
1990 127
1991 127
1992 131
1993 143
1994 109
1995 142
1996 123
1997 122
1998 132
1999 111
2000 106
2001 100
2002 98
2003 84
2004 80
2005 78
2006 86
2007 96
2008 101
2009 65
2010 75
2011 77
2012 66
2013 80
2014 56
2015 64
2016 65
2017 56
2018 46
2019 58
2020 60
2021 59
2022 41
2023 48
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

4,208 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics of serotonergic drugs: focus on OCD.
Marazziti D, Avella MT, Basile L, Mucci F, Dell'Osso L. Marazziti D, et al. Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):261-273. doi: 10.1080/17425255.2019.1584611. Epub 2019 Mar 8. Expert Opin Drug Metab Toxicol. 2019. PMID: 30793987 Review.
Areas covered: The aim of this paper was to review the literature on the pharmacokinetics of SSRIs and clomipramine, and on their pharmacokinetic parameters in OCD patients. Expert opinion: Although the literature on the pharmacokinetics of both clomipramine and SSR …
Areas covered: The aim of this paper was to review the literature on the pharmacokinetics of SSRIs and clomipramine, and on their pha …
Recombinant laccase: II. Medical biosensor.
Bragazzi NL, Pechkova E, Scudieri D, Terencio TB, Adami M, Nicolini C. Bragazzi NL, et al. Crit Rev Eukaryot Gene Expr. 2012;22(3):197-203. doi: 10.1615/critreveukargeneexpr.v22.i3.30. Crit Rev Eukaryot Gene Expr. 2012. PMID: 23140161 Review.
Recombinant fungal laccase from Rigidoporous lignosus, as previously described, was used to catalyze a widely used antidepressant in a micromolar range, namely, clomipramine. The topological properties of the laccase thin film were characterized via LB pi-A isotherm and AF …
Recombinant fungal laccase from Rigidoporous lignosus, as previously described, was used to catalyze a widely used antidepressant in a micro …
A comparative trial of Anafranil, Pertofran and an Anafranil/Pertofran combination.
Murphy JE. Murphy JE. J Int Med Res. 1977;5(1 Suppl):16-23. J Int Med Res. 1977. PMID: 324830 Clinical Trial.
On the grounds of different pharmacological properties and possibly different clinical effects, two antidepressants, Anafranil (clomipramine) and Pertofran (desipramine) were compared in the management of depression in general practice. ...Ninety-one per cent of the …
On the grounds of different pharmacological properties and possibly different clinical effects, two antidepressants, Anafranil (cl …
Drug-induced mania.
Mundo E, Ronchi P, Bellodi L. Mundo E, et al. Hosp Community Psychiatry. 1993 Jul;44(7):689-90. doi: 10.1176/ps.44.7.689-b. Hosp Community Psychiatry. 1993. PMID: 8354514 No abstract available.
Drug treatment of obsessive-compulsive disorder.
Zohar J, Insel TR. Zohar J, et al. J Affect Disord. 1987 Sep-Oct;13(2):193-202. doi: 10.1016/0165-0327(87)90023-1. J Affect Disord. 1987. PMID: 2960711 Review.
Moreover, in recent years controlled studies demonstrated that clomipramine is more effective than placebo and than other tricyclics for reducing obsessive-compulsive symptoms. ...The apparent specificity of clomipramine, and, to some extent, newer serotonin selecti …
Moreover, in recent years controlled studies demonstrated that clomipramine is more effective than placebo and than other tricyclics …
A pilot study of anafranil in the treatment of phobic states.
Colgan A. Colgan A. Scott Med J. 1975;20(1 SUPPL):55-60. doi: 10.1177/00369330750200S112. Scott Med J. 1975. PMID: 1154016
A pilot study of the use of Anafranil in the treatment of phobic disorders is described. Twenty-two patients were included in the investigation, 16 receiving intravenous and oral Anafranil combined and six oral Anafranil alone. ...
A pilot study of the use of Anafranil in the treatment of phobic disorders is described. Twenty-two patients were included in the inv …
Obsessive-compulsive disorder.
George MS. George MS. Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:57-66; discussion 66-8. Int Clin Psychopharmacol. 1991. PMID: 1806635 Review.
4,208 results